C2Sense

2 known investors

Hyperion Biosystems builds diagnostic devices that use computer vision and physics-based algorithms to improve the sensitivity and specificity of point-of-care and at-home tests. Its products include the HALO platform and Helios, a rapid molecular diagnostic platform combining padlock probe chemistry, isothermal amplification, and optical readout for multiplexed, single-copy detection.